Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial Transcriptomics services are now ...
Xenium In Situ demonstrates higher transcript counts per gene in new comparison study of three spatial imaging platforms PLEASANTON, Calif., Dec. 13, 2023 /PRNewswire/ -- 10x Genomics, Inc. (TXG) ...
PLEASANTON, Calif., June 20, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping its new Xenium Prime 5K ...
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology "Scientists can now ...
StockStory.org on MSN
TXG Q4 deep dive: Consumables growth, spatial expansion, and AI-driven demand shape outlook
Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2025 results , but sales were flat year on year at $166 million. The ...
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, ...
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region ASTRA will bring together molecular and spatial data ...
SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...
“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results